Following the announcement of a partnership with Wolters Kluwer Health, Cerner's stock jumped to $55.98, a 52-week high, according to a NASDAQ Blog report.
The partnership will focus on the development of a dynamic clinical documentation solution to help capture all relevant information and provide clinical decision support.
"As physicians have transitioned from paper to the usage of electronic medical records, the patient's story has been lost. Our agreement with Wolters Kluwer Health will allow us to preserve the narrative while structuring key aspects of the note that then can be leveraged for clinical decision support to record and review more relevant information at the point of care," said Brian Lancaster, vice president of physician strategy at Cerner, in a news release. "This will allow physicians to improve the quality of care they are providing while maintaining the highest levels of productivity."
Cerner's new share price represents a one-year return of 54.5 percent and a year-to-date return of 39.1 percent, according to the report.
More Articles on the Health IT Market:
Lexmark Acquires PACSGEAR for $54M
CareCloud Reports 3rd Quarter Growth, 440 New Customers
Greenway, Harland Technology Partner for Ambulatory Health IT